Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-08-22
2006-08-22
Mosher, Mary E. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S228100, C530S300000, C530S350000, C530S324000, C530S325000, C530S326000, C530S327000, C530S328000, C435S235100
Reexamination Certificate
active
07094406
ABSTRACT:
Viral proteins derived from an enterically transmitted non-A
on-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in individuals infected with the viral hepatitis agent. This protein is useful in a diagnostic method for detecting infection by the enterically transmitted agent. Specific epitopes have been identified that are reactive with sera of individual infected with different strains of HEV. Also disclosed are DNA probes derived from a cloned sequence of the viral agent. These probes are useful for identifying and sequencing the entire viral agent and for assaying the presence of the viral agent in an infected sample, by using probe-specific amplification of virus-derived DNA fragments.
REFERENCES:
patent: 4659678 (1987-04-01), Forrest et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4871659 (1989-10-01), Pillot
patent: 5077193 (1991-12-01), Mishiro et al.
patent: 5770689 (1998-06-01), Reyes et al.
patent: 5789559 (1998-08-01), Reyes et al.
patent: 5824649 (1998-10-01), Reyes et al.
patent: 2 606 515 (1988-05-01), None
patent: 2 609 807 (1988-06-01), None
patent: 85/01517 (1985-04-01), None
patent: 88/03410 (1988-05-01), None
patent: 89/12641 (1989-12-01), None
Zhang et al (Clinical and Diagnostic Laboratory Immunology 4:423-428, 1997).
Aggarwal et al (Journal of Gastroenterology and Hepatology 15:9-20, 2000).
Lewin, R., “When Does Homology Mean Something Else?,”Science, 237:1570 (1987).
New England Bio Labs 1988-1989 Catalog, p. 62.
Sambrook, J., et al.,Molecular Cloning, A Laboratory Manual, vol. 2, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp. 8.46-8.49, 11.11-11.57 (1989).
Sambrook, J., et al.,Molecular Cloning, A Laboratory Manual, vol. 2, Cold Spring Harbor Laboratory Press, Cold Spring harbor, New York, pp. B.20 (1989).
Sarthou, J.I., et al., “Characterization of an Antigen-Antibody System Associated with Epidemic Non-A, Non-B Hepatitis in West Africa and Experimental Transmission of an Infectious Agent to Primates,”AIM. Inst. Pasteur/Virol., 137(F): 225-232 (1986).
Sigma Chemical Company, “Sigma Price List 1987,” p. 1024 (1987).
Bradley Daniel W.
Fry Kirk E.
Krawczynski Krzysztof Z.
Reyes Gregory R.
Tam Albert W.
Dehlinger Peter
Mosher Mary E.
Perkins Coie LLP
The United States of America as represented by the Secretary of
Yang Junrui
LandOfFree
Enterically transmitted non-A/non-B hepatitis viral agent... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enterically transmitted non-A/non-B hepatitis viral agent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enterically transmitted non-A/non-B hepatitis viral agent... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3634466